HUE025484T2 - Adapalén és benzoil-peroxid alkalmazása akne vulgarisz hosszú távú kezelésére - Google Patents
Adapalén és benzoil-peroxid alkalmazása akne vulgarisz hosszú távú kezelésére Download PDFInfo
- Publication number
- HUE025484T2 HUE025484T2 HUE08708470A HUE08708470A HUE025484T2 HU E025484 T2 HUE025484 T2 HU E025484T2 HU E08708470 A HUE08708470 A HU E08708470A HU E08708470 A HUE08708470 A HU E08708470A HU E025484 T2 HUE025484 T2 HU E025484T2
- Authority
- HU
- Hungary
- Prior art keywords
- adapalene
- weight
- acne
- study
- subjects
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Claims (9)
- Szabadalmi igénypontok í. Adapaiênl és beozoü-peroxidot tartalmazó készítmény alkalmazása erre szoruló betegnek történő,; akise valgarisz hosszú iává kezelését biztosító adagolásra szolgaié tspikális gyógyszerkészítmény előállítására, ahol a készítmény totatea* adapaléol és feenzotl-peroxidot Ωχ: dózisú kombinációban, és a ieplkálls gyégyssmrfcészítmény adagolási média feMeïî a készítmény terápiásait batásos mennyiségének legalább 9 hónapon és legíé§ebh 12 hónapost keresztüli adagolását
- 2, Μ I, igénypont szerinti alkalmazás, afeol a topikális gyógyszerkészítmény naponta adagolandó, és előnyösen naponta egyszer.
- 3. Az 1. igénypont szerinti alkalmazás, ahol a lopikáiis gyógyszerkészítmény minden második napon adagolandó,
- 4 Az 1-3, igénypontok Mrmelyike szerimi alkalmazás, ahol a topikális gyógyszerkészítmény este adagolandó a mosakodást követéért.
- 5, Az 1-4, igénypontok bármelyike szerinti: alkalmazás, aboi s topikális gyógyszerkészítmény gél készítmény.
- 6, Az 1, igénypont szerinti alkalmazás, ahol a topikális gyógyszerkészítmény tartalmaz legalább 0,001 tSmeg% ndapalént a készítmény teljés tömegére vonatkoztatva.
- 7, Az i, igénypont szerinti alkalmazás, ahol & topikális gyógyszerkészítmény tartalmaz 0,01-2 tömeg% ádapalént, előnyősén tattalmaz 0,01-0,5 tömeg%, legelőnyösebben 0,1-0,3 tömegé adapaiént a készítmény teljes tömegére vonatkoztatva.
- 8, A 6, vagy '7, igénypont szerinti alkalmazás, ahol a topikális gyógyszerkészítmény tartalmaz: Ô.025-20 tömegéi henzoil-peroxidot, előnyőseit tartalmaz 2-10 tömeg% BPÖ-t, legelőnyösebben 2,5-5 törneg% bensői)· peroxidot a készítmény teljes tömegére vonatkoztatva,
- 9, Az 1. igénypont szerinti alkalmazás, ahoi a topikális gyógyszerkészitmény tartalmaz 0,t íStneg% adapaiént és 2,5 tömegéi benzoil-peroxidöt és: naponta egyszer aikalsHazaodó a betegséggel érintett bőrön.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89811307P | 2007-01-30 | 2007-01-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE025484T2 true HUE025484T2 (hu) | 2016-02-29 |
Family
ID=39473958
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE08708470A HUE025484T2 (hu) | 2007-01-30 | 2008-01-30 | Adapalén és benzoil-peroxid alkalmazása akne vulgarisz hosszú távú kezelésére |
Country Status (16)
Country | Link |
---|---|
US (3) | US8809305B2 (hu) |
EP (1) | EP2114392B1 (hu) |
JP (1) | JP2011510907A (hu) |
AR (1) | AR065085A1 (hu) |
AU (1) | AU2008209730B2 (hu) |
CA (1) | CA2677167A1 (hu) |
CY (1) | CY1116672T1 (hu) |
DK (1) | DK2114392T3 (hu) |
ES (1) | ES2546029T3 (hu) |
HR (1) | HRP20150940T1 (hu) |
HU (1) | HUE025484T2 (hu) |
PL (1) | PL2114392T3 (hu) |
PT (1) | PT2114392E (hu) |
RU (1) | RU2481832C2 (hu) |
SI (1) | SI2114392T1 (hu) |
WO (1) | WO2008092911A1 (hu) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7820186B2 (en) | 2001-12-21 | 2010-10-26 | Galderma Research & Development | Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
CA2870690A1 (en) * | 2012-05-25 | 2013-11-28 | Galderma Research & Development | Treatment of preadolescent moderate acne vulgaris |
WO2015150332A1 (en) * | 2014-04-01 | 2015-10-08 | Galderma Research & Development | Combination of adapalene and benzoyl peroxide for treating acne scars |
MX2018002176A (es) * | 2015-08-20 | 2018-06-15 | Sol Gel Tech Ltd | Composiciones para aplicaciones topicas que comprenden peroxido de benzoilo y adapaleno. |
US10722488B2 (en) * | 2016-06-07 | 2020-07-28 | Rodan & Fields, Llc | Hest G-18-0 and benzoyl peroxide compositions and methods for using the same |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02502578A (ja) * | 1987-12-05 | 1990-08-16 | レニショウ パブリック リミテッド カンパニー | 検知デバイス交換装置 |
US5327657A (en) * | 1991-07-11 | 1994-07-12 | Renishaw Metrology Ltd. | Touch probe |
US5393288A (en) * | 1991-11-26 | 1995-02-28 | Mutoh Industries Ltd. | Three-dimensional processing machine and a method of processing a workpiece |
TW203552B (en) * | 1992-02-18 | 1993-04-11 | J Baroody Lloyd | Compositions of clindamycin and benzoyl peroxide for acne treatment |
US5646049A (en) * | 1992-03-27 | 1997-07-08 | Abbott Laboratories | Scheduling operation of an automated analytical system |
US6559189B2 (en) * | 1999-04-28 | 2003-05-06 | Regents Of The University Of Michigan | Non-toxic antimicrobial compositions and methods of use |
GB0115788D0 (en) * | 2001-06-28 | 2001-08-22 | Renishaw Plc | Tool identification |
US6572312B2 (en) * | 2001-07-20 | 2003-06-03 | Cottrell, Inc. | Power screw load retention apparatus and system |
GB0129471D0 (en) * | 2001-12-10 | 2002-01-30 | Renishaw Plc | Rack and change system |
US7820186B2 (en) | 2001-12-21 | 2010-10-26 | Galderma Research & Development | Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
FR2833841B1 (fr) * | 2001-12-21 | 2005-07-22 | Galderma Res & Dev | Gel comprenant au moins un retinoide et du peroxyde de benzoyle |
US20060128808A1 (en) * | 2004-10-20 | 2006-06-15 | Galderma Research & Development, S.N.C. | Method of using adapalene in acne maintenance therapy |
AU2006208705B9 (en) * | 2005-01-26 | 2012-02-02 | Galderma Research & Development | Adapalene for the long-term treatment of acne vulgaris |
AR054805A1 (es) * | 2005-06-29 | 2007-07-18 | Stiefel Laboratories | Composiciones topicas para el tratamiento de la piel |
FR2903603B1 (fr) | 2006-07-13 | 2009-03-20 | Galderma Res & Dev S N C Snc | Combinaison d'adapalene et de peroxyde de benzole dans le traitement de l'acne |
WO2008006848A1 (en) * | 2006-07-13 | 2008-01-17 | Galderma Research & Development | Composition comprising a retinoid and benzoyl peroxide |
-
2008
- 2008-01-30 SI SI200831492T patent/SI2114392T1/sl unknown
- 2008-01-30 RU RU2009132502/15A patent/RU2481832C2/ru active
- 2008-01-30 EP EP08708470.3A patent/EP2114392B1/en not_active Revoked
- 2008-01-30 AR ARP080100366A patent/AR065085A1/es unknown
- 2008-01-30 ES ES08708470.3T patent/ES2546029T3/es active Active
- 2008-01-30 PL PL08708470T patent/PL2114392T3/pl unknown
- 2008-01-30 PT PT87084703T patent/PT2114392E/pt unknown
- 2008-01-30 CA CA002677167A patent/CA2677167A1/en not_active Abandoned
- 2008-01-30 WO PCT/EP2008/051155 patent/WO2008092911A1/en active Application Filing
- 2008-01-30 JP JP2009547688A patent/JP2011510907A/ja active Pending
- 2008-01-30 DK DK08708470.3T patent/DK2114392T3/en active
- 2008-01-30 AU AU2008209730A patent/AU2008209730B2/en active Active
- 2008-01-30 HU HUE08708470A patent/HUE025484T2/hu unknown
-
2009
- 2009-07-29 US US12/458,982 patent/US8809305B2/en active Active
-
2014
- 2014-07-22 US US14/337,823 patent/US20140336257A1/en not_active Abandoned
-
2015
- 2015-09-07 HR HRP20150940TT patent/HRP20150940T1/hr unknown
- 2015-09-07 CY CY20151100776T patent/CY1116672T1/el unknown
-
2017
- 2017-04-21 US US15/494,218 patent/US20170216235A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US8809305B2 (en) | 2014-08-19 |
AR065085A1 (es) | 2009-05-13 |
US20170216235A1 (en) | 2017-08-03 |
US20100029762A1 (en) | 2010-02-04 |
EP2114392A1 (en) | 2009-11-11 |
RU2481832C2 (ru) | 2013-05-20 |
JP2011510907A (ja) | 2011-04-07 |
AU2008209730A1 (en) | 2008-08-07 |
RU2009132502A (ru) | 2011-03-10 |
AU2008209730B2 (en) | 2013-08-15 |
PL2114392T3 (pl) | 2015-11-30 |
EP2114392B1 (en) | 2015-06-10 |
DK2114392T3 (en) | 2015-09-07 |
CY1116672T1 (el) | 2017-03-15 |
US20140336257A1 (en) | 2014-11-13 |
HRP20150940T1 (hr) | 2015-11-20 |
SI2114392T1 (sl) | 2016-01-29 |
ES2546029T3 (es) | 2015-09-17 |
PT2114392E (pt) | 2015-10-13 |
WO2008092911A1 (en) | 2008-08-07 |
CA2677167A1 (en) | 2008-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Thiboutot | New treatments and therapeutic strategies for acne | |
Mohsin et al. | Acne treatment review and future perspectives | |
Thielitz et al. | Topical retinoids in acne–an evidence‐based overview | |
Benner et al. | Overview of the treatment of acne vulgaris | |
US20170216235A1 (en) | Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris | |
BRPI0611713A2 (pt) | composições tópicas para tratamento da pele | |
US20040171561A1 (en) | Topical formulations for treatment of rosacea | |
Spellman et al. | Efficacy and safety of azelaic acid and glycolic acid combination therapy compared with tretinoin therapy for acne | |
Olsen | Therapy of acne | |
EP2265268A2 (en) | Stable fixed dose topical formulation | |
US7642288B2 (en) | Topical application of adapalene for the long-term treatment of acne vulgaris | |
SG176097A1 (en) | Topical retinoid solutions | |
US20210113511A1 (en) | Methods and compositions for the treatment of acne | |
Anastassakis | Retinoic Acid | |
Rahimi et al. | Comprehensive Management of Acne Vulgaris: Integrating Non-Antibiotic Therapies to Mitigate Resistance and Drug-Induced Discomfort and Pain Management | |
Tolaymat et al. | Continuing Education Activity | |
Alikhan et al. | Keratolytic treatment of acne | |
MXPA00007720A (en) | Anhydrous topical skin preparations |